Antiviral drug discovery: Pyrimidine entry inhibitors for Zika and dengue viruses
- 30 April 2024
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 272, 116465
Abstract
No abstract availableKeywords
Funding Information
- Agencia Nacional de Promoción Científica y Tecnológica (PICT 2017-3767, PICT 2020-3371)
- Agencia Nacional de Promoción Científica y Tecnológica
- CONICET (11220210100168, PIP 11220130100721)
This publication has 35 references indexed in Scilit:
- A pan-serotype antiviral to prevent and treat dengue: A journey from discovery to clinical development driven by public-private partnershipsAntiviral Research, 2022
- Structural modification aimed for improving solubility of lead compounds in early phase drug discoveryBioorganic & Medicinal Chemistry, 2022
- The synthesis of 4-arylamido-2-arylaminoprimidines as potent EGFR T790M/L858R inhibitors for NSCLCBioorganic & Medicinal Chemistry, 2018
- Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope ProteinCell Chemical Biology, 2018
- Improvement in aqueous solubility achieved via small molecular changesBioorganic & Medicinal Chemistry Letters, 2017
- Synthesis, Characterization, and DGAT1 Inhibition of New 5‐Piperazinethiazole and 5‐Piperidinethiazole AnalogsJournal of Heterocyclic Chemistry, 2014
- Extension into the entrance channel of HIV-1 reverse transcriptase—Crystallography and enhanced solubilityBioorganic & Medicinal Chemistry Letters, 2013
- Design, synthesis and 3D-QSAR analysis of novel 2-hydrazinyl-4-morpholinothieno[3,2-d]pyrimidine derivatives as potential antitumor agentsEuropean Journal of Medicinal Chemistry, 2012
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996